DEEP RESEARCH · EASY BIO/INVESTMENT REVIEW
[Easy Bio] Investment Closed
An exit memo that still acknowledges company quality and upside, while prioritizing portfolio compression
0. Bottom line first
Easy Bio looks like a good company with upside, but I am letting it go for now to compress the portfolio. I still think the upside could be enough to buy even after a break above the prior high, but because I studied it only recently, I am setting it aside for now.
1. Decision structure
Good company
The original note describes Easy Bio as a good company and says upside appears to exist.
Revisit above the prior high
The note says the upside still looks meaningful enough that buying after a prior-high breakout could be acceptable.
Compress the portfolio
Because the company was studied only recently, it is being set aside during this portfolio-compression step.
2. Prior analysis link
The referenced prior post is https://blog.naver.com/star_of_self/223798062081. The link card title is [Easy Bio] Will U.S. pork increase in 2025?, and its summary says fourth-quarter 2024 results were quite strong and that a sudden change in shareholder returns made the company worth watching.
Interpretation: This reads less like a negative exit and more like a review note: keep the upside candidate in mind, but focus the current portfolio on higher-conviction positions.
3. Nature of the record
This is not a buy or sell recommendation. It is a note kept for future review; even where the original text contains typos, the point is to preserve the trace of the investment decision.
Sources
- Original post: Naver Blog original
- Prior analysis post: https://blog.naver.com/star_of_self/223798062081